• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高剂量口服阿昔洛韦治疗急性眼带状疱疹:皮质类固醇时代的终结。

High-dose oral acyclovir in acute herpes zoster ophthalmicus: the end of the corticosteroid era.

作者信息

Herbort C P, Buechi E R, Piguet B, Zografos L, Fitting P

机构信息

Hopital Ophtalmique Jules Gonin, Department of Ophthalmology, University of Lausanne, Switzerland.

出版信息

Curr Eye Res. 1991;10 Suppl:171-5. doi: 10.3109/02713689109020375.

DOI:10.3109/02713689109020375
PMID:1864091
Abstract

Systemic acyclovir (ACV), a new potent anti-herpes drug, was shown to reduce effectively the morbidity in the acute phase of herpes zoster ophthalmicus (AHZO). Using high dose oral ACV (5 X 800 mg/day) our aim in this study was: (1) to compare disease profiles in the ACV-treated group and in a group of zoster patients having had no ACV, analysed retrospectively; (2) to establish if high-dose ACV was able to prevent severe long term complications of AHZO; and (3) to determine the present role of corticosteroids in AHZO. From 1984 to 1988, 48 patients with AHZO of less than 3 days' duration were included. All patients received at least 7 days of oral ACV (5 X 800 mg/d) associated with topical ACV. Steroids were not given unless severe uveitis occurred. Follow-up was 2 years in 43 patients and 1 year in all 48 patients. Main conclusions from our study are: 1. Ocular involvement occurred in 67% of ACV-treated cases, a rate comparable to our retrospective group (59%) and to the literature (71%). However the rate of severe long term complications was minimal (4%) when compared to our non-treated retrospective group (21%). 2. Steroid treatment was not necessary in any of the ACV-treated patients. 3. ACV was well tolerated and did not have to be discontinued in any of the patients. High dose ACV and avoidance of steroids seems to eliminate the severe complications of AHZO.

摘要

全身性无环鸟苷(ACV)是一种新型强效抗疱疹药物,已证明它能有效降低眼部带状疱疹急性期(AHZO)的发病率。本研究采用高剂量口服ACV(5×800毫克/天),目的是:(1)回顾性分析比较ACV治疗组和未使用ACV的带状疱疹患者组的疾病情况;(2)确定高剂量ACV是否能够预防AHZO的严重长期并发症;(3)确定皮质类固醇在AHZO中的当前作用。1984年至1988年,纳入了48例病程少于3天的AHZO患者。所有患者均接受至少7天的口服ACV(5×800毫克/天)并联合局部使用ACV。除非发生严重葡萄膜炎,否则不给予类固醇。43例患者随访2年,48例患者全部随访1年。我们研究的主要结论是:1. ACV治疗组中67%出现眼部受累,这一比例与我们的回顾性组(59%)及文献报道(71%)相当。然而,与未治疗的回顾性组(21%)相比,严重长期并发症的发生率极低(4%)。2. 在任何接受ACV治疗的患者中均无需使用类固醇治疗。3. ACV耐受性良好,所有患者均无需停药。高剂量ACV和避免使用类固醇似乎可消除AHZO的严重并发症。

相似文献

1
High-dose oral acyclovir in acute herpes zoster ophthalmicus: the end of the corticosteroid era.高剂量口服阿昔洛韦治疗急性眼带状疱疹:皮质类固醇时代的终结。
Curr Eye Res. 1991;10 Suppl:171-5. doi: 10.3109/02713689109020375.
2
[Prevention of ocular complications of herpes zoster ophthalmicus by adequate treatment with acyclovir].[通过阿昔洛韦充分治疗预防眼部带状疱疹的眼部并发症]
Klin Monbl Augenheilkd. 1991 May;198(5):358-60. doi: 10.1055/s-2008-1045980.
3
Influence of oral acyclovir on ocular complications of herpes zoster ophthalmicus.口服阿昔洛韦对眼部带状疱疹眼部并发症的影响。
Eye (Lond). 1994;8 ( Pt 1):70-4. doi: 10.1038/eye.1994.13.
4
Oral acyclovir for herpes zoster ophthalmicus.口服阿昔洛韦治疗眼部带状疱疹。
Ophthalmology. 1992 Jul;99(7):1062-70; discussion 1070-1. doi: 10.1016/s0161-6420(92)31849-4.
5
Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus.伐昔洛韦与阿昔洛韦治疗眼部带状疱疹的疗效及安全性比较。
Ophthalmology. 2000 Aug;107(8):1507-11. doi: 10.1016/s0161-6420(00)00222-0.
6
Oral acyclovir in herpes zoster ophthalmicus.口服阿昔洛韦治疗眼部带状疱疹。
Curr Eye Res. 1991;10 Suppl:177-82. doi: 10.3109/02713689109020376.
7
Double-masked trial of topical acyclovir and steroids in the treatment of herpes zoster ocular inflammation.局部用阿昔洛韦和类固醇治疗带状疱疹性眼部炎症的双盲试验。
Br J Ophthalmol. 1991 Sep;75(9):542-6. doi: 10.1136/bjo.75.9.542.
8
Oral acyclovir in the treatment of acute herpes zoster ophthalmicus.口服阿昔洛韦治疗急性眼带状疱疹
Ophthalmology. 1986 Jun;93(6):763-70. doi: 10.1016/s0161-6420(86)33678-9.
9
A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis.局部用阿昔洛韦与类固醇治疗带状疱疹性角膜葡萄膜炎的比较。
Br J Ophthalmol. 1983 Nov;67(11):746-50. doi: 10.1136/bjo.67.11.746.
10
Oral acyclovir in the therapy of acute herpes zoster ophthalmicus. An interim report.口服阿昔洛韦治疗急性眼带状疱疹。中期报告。
Ophthalmology. 1985 Nov;92(11):1574-83. doi: 10.1016/s0161-6420(85)33842-3.

引用本文的文献

1
Inadequacies in uveitis: misnomers, incongruencies, persistence of obsolete terminologies & inappropriate guidelines, treatment inadequacies, and misinterpretations.葡萄膜炎的不足之处:名称不当、不一致、过时术语的持续存在及不恰当的指南、治疗不足和误解。
J Ophthalmic Inflamm Infect. 2025 Mar 6;15(1):19. doi: 10.1186/s12348-025-00470-0.
2
Effect of SARS-CoV-2 mRNA vaccination on ocular herpes simplex and varicella-zoster virus reactivation: should preventive antiviral treatment be given in known herpes patients.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)信使核糖核酸(mRNA)疫苗接种对眼部单纯疱疹和水痘-带状疱疹病毒再激活的影响:对于已知的疱疹患者是否应给予预防性抗病毒治疗。
J Ophthalmic Inflamm Infect. 2021 Sep 17;11(1):33. doi: 10.1186/s12348-021-00262-2.
3
Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination - report of three cases.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗接种后水痘-带状疱疹病毒再激活导致眼部带状疱疹(HZO)——三例报告
J Ophthalmic Inflamm Infect. 2021 Sep 16;11(1):28. doi: 10.1186/s12348-021-00260-4.
4
Comment on 'Herpes zoster ophthalmicus reduction: implementation of shingles vaccination in the UK'.关于“眼部带状疱疹发病率降低:英国带状疱疹疫苗的实施”的评论
Eye (Lond). 2014 Dec;28(12):1522-3. doi: 10.1038/eye.2014.204. Epub 2014 Sep 5.
5
Response to Dr Clearkin.对克拉克金博士的回应。
Eye (Lond). 2014 Dec;28(12):1523. doi: 10.1038/eye.2014.205. Epub 2014 Sep 5.
6
Varicella-zoster virus keratitis with asymptomatic conjunctival viral shedding in the contralateral eye.水痘-带状疱疹病毒性角膜炎伴对侧眼无症状性结膜病毒脱落
Case Rep Ophthalmol. 2012 Sep;3(3):343-8. doi: 10.1159/000343463. Epub 2012 Oct 6.
7
CNS diseases and uveitis.中枢神经系统疾病与葡萄膜炎。
J Ophthalmic Vis Res. 2011 Oct;6(4):284-308.
8
Recognition and treatment of shingles.带状疱疹的识别与治疗。
Drugs. 1994 Oct;48(4):528-48. doi: 10.2165/00003495-199448040-00004.